Abbott Laboratories India
India bans Pfizer, Abbot cough syrups; shares tank
14 Mar 2016
The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling
Abbott to buy rapid diagnostic testing provider Alere for $5.8 bn
02 Feb 2016
The acquisition will enable Abbott to become the leading provider of point of care diagnostic testing with total sales exceeding $7 billion from $4.6 billion currently
Abbott Laboratories to back Mylan-Perrigo deal
17 Jun 2015
Maruti joins Boeing, Abbott, Honeywell to back India’s IPR regime
04 Jun 2014
The support comes against a backdrop of US industry and trade lobbies objecting to India's rejection of patents for Bristol-Myers Squibb's Sprycel and Novartis AG's Glivec
Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal
17 May 2014
This is Abbott’s first multi-billion dollar deal after it spun off some of its research-based pharmaceuticals business last year
